Home
 /
Papers
 /
Genomics
 /
Single-Cell Atlas of Transcription and Chromatin States Reveals Regulatory Programs in the Human Brain
Preprint
Open access
V1
Top 1% · Validated by QED

Single-Cell Atlas of Transcription and Chromatin States Reveals Regulatory Programs in the Human Brain

Yang Xie, Lei Chang, Guojie Zhong +52 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.02.02.703166
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genomics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Mapping transcription and histone states in 750,000 human brain nuclei, this atlas reveals neuron-specific Polycomb loops as an architectural memory mechanism and unlocks systematic interpretation of noncoding variants across neuropsychiatric disorders.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

We created detailed molecular maps of individual brain cells that reveal how the genome is turned on and off to produce the remarkable diversity of cell types in the mouse and human brains. Our work shows that gene silencing is an active and informative process, not simply the absence of gene activity, and helps preserve the developmental history and identity of brain cells. These maps also identify the DNA switches and cell types linked to neurological and psychiatric diseases. Finally, we trained artificial intelligence models to predict how DNA sequences control brain function, providing a powerful framework for understanding disease-causing genetic variants and designing future therapies.

”
Bing Ren

QED claims analysis

Summary

Joint single-cell profiling of transcriptomes with active (H3K27ac) and repressive (H3K27me3) histone modifications across >750,000 nuclei in the adult human brain functionally resolves >500,000 regulatory elements into distinct chromatin states, revealing that cellular identity is maintained through coordinated activation of lineage-specific programs and Polycomb-mediated repression of developmental genes organized within neuron-specific super long-range chromatin loops, enabling systematic interpretation of neuropsychiatric disease variants through cell-type-resolved enhancer-gene links and gene regulatory networks.

See full analysis
Main Claim 1 –

Joint single-cell RNA and H3K27ac/me3 atlas resolves 160 cell clusters

Supporting evidence

  • Histone marks reveal oligodendrocyte regional programs beyond transcriptomes
Main Claim 2 –

Multimodal chromatin states classify >500,000 cCREs as active or repressed

Supporting evidence

  • Spatial integration shows laminar H3K27ac/me3 gradients precede transcription shifts
  • Active regulatory grammar conserved, repressive chromatin more evolutionarily divergent
Main Claim 3 –

Cell-type enhancer-gene links and GRNs map noncoding disease variants

Supporting evidence

  • Neuron super long-range Polycomb loops silence developmental genes

Abstract

Directly measuring chromatin states alongside transcription is essential for understanding how cell-type-specific regulatory programs are established and maintained in the adult human brain. We present a large-scale single-cell multimodal atlas generated by jointly profiling transcriptome with active (H3K27ac) and repressive (H3K27me3) histone modifications across 18 brain regions. We profile >750,000 nuclei spanning 160 cell types and integrate these data with chromatin accessibility, DNA methylation, 3D genome architecture, and spatial transcriptome. This framework annotates >500,000 regulatory elements and resolves cell-type-specific chromatin states. We link enhancers to target genes, infer gene regulatory networks, and classify chromatin interactions, revealing neuron-enriched long-range Polycomb repression of developmental genes. Integrating these maps with GWAS data and sequence-based model prioritizes noncoding variants, effector genes, and vulnerable cell types for neuropsychiatric disorders. Finally, cross-species comparisons show conserved activation but more divergent repression. Together, this study provides a functional reference for interpreting noncoding variants, epigenetic memory, and brain organization.

HIGHLIGHTS

Joint single-cell profiling of transcriptomes with active or repressive histone modification in >750,000 nuclei across adult human brain.

Chromatin state annotation of >500,000 candidate cis-regulatory elements distinguishes active enhancers from accessible and Polycomb-repressed regions.Cell-type-resolved regulatory networks and sequence-based deep learning model prioritize functional neuropsychiatric risk variants.

Spatial epigenomic imputation reveals laminar layer-specific Polycomb repression programs.Integration with 3D genome architecture reveals neuron-specific super long-range chromatin loops silencing early developmental genes.

Evolutionary analysis uncovers conserved active regulatory grammar but divergent repressive landscape.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?